Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-18

FDA Approved: HALOPERIDOL — Original Application (Creekwood Pharmaceuticals LLC)

View source ↗

Summary

FDA approved Creekwood Pharmaceuticals' generic haloperidol under an original ANDA (ANDA 218162).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL (HALOPERIDOL LACTATE)

Snippet

ORIG AP for HALOPERIDOL (HALOPERIDOL)